These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

237 related items for PubMed ID: 11805203

  • 21. Endothelin converting enzyme inhibitor protects development of right ventricular overload and medial thickening of pulmonary arteries in rats with monocrotaline-induced pulmonary hypertension.
    Takahashi T, Kanda T, Inoue M, Sumino H, Kobayashi I, Iwamoto A, Nagai R.
    Life Sci; 1998; 63(10):PL137-43. PubMed ID: 9734710
    [Abstract] [Full Text] [Related]

  • 22. Pioglitazone alleviates cardiac and vascular remodelling and improves survival in monocrotaline induced pulmonary arterial hypertension.
    Behringer A, Trappiel M, Berghausen EM, Ten Freyhaus H, Wellnhofer E, Odenthal M, Blaschke F, Er F, Gassanov N, Rosenkranz S, Baldus S, Kappert K, Caglayan E.
    Naunyn Schmiedebergs Arch Pharmacol; 2016 Apr; 389(4):369-79. PubMed ID: 26742933
    [Abstract] [Full Text] [Related]

  • 23. Endothelin-1 is elevated in monocrotaline pulmonary hypertension.
    Frasch HF, Marshall C, Marshall BE.
    Am J Physiol; 1999 Feb; 276(2):L304-10. PubMed ID: 9950893
    [Abstract] [Full Text] [Related]

  • 24. Preventive effects of raloxifene, a selective estrogen receptor modulator, on monocrotaline-induced pulmonary hypertension in intact and ovariectomized female rats.
    Nishida M, Hasegawa Y, Tanida I, Nakagawa E, Inaji H, Ohkita M, Matsumura Y.
    Eur J Pharmacol; 2009 Jul 01; 614(1-3):70-6. PubMed ID: 19379725
    [Abstract] [Full Text] [Related]

  • 25. Endostatin is protective against monocrotaline-induced right heart disease through the inhibition of T-type Ca(2+) channel.
    Imoto K, Kumatani S, Okada M, Yamawaki H.
    Pflugers Arch; 2016 Jul 01; 468(7):1259-1270. PubMed ID: 27023352
    [Abstract] [Full Text] [Related]

  • 26. Apelin decreases myocardial injury and improves right ventricular function in monocrotaline-induced pulmonary hypertension.
    Falcão-Pires I, Gonçalves N, Henriques-Coelho T, Moreira-Gonçalves D, Roncon-Albuquerque R, Leite-Moreira AF.
    Am J Physiol Heart Circ Physiol; 2009 Jun 01; 296(6):H2007-14. PubMed ID: 19346461
    [Abstract] [Full Text] [Related]

  • 27. Selective activation of angiotensin AT2 receptors attenuates progression of pulmonary hypertension and inhibits cardiopulmonary fibrosis.
    Bruce E, Shenoy V, Rathinasabapathy A, Espejo A, Horowitz A, Oswalt A, Francis J, Nair A, Unger T, Raizada MK, Steckelings UM, Sumners C, Katovich MJ.
    Br J Pharmacol; 2015 May 01; 172(9):2219-31. PubMed ID: 25522140
    [Abstract] [Full Text] [Related]

  • 28. Copaiba Oil Attenuates Right Ventricular Remodeling by Decreasing Myocardial Apoptotic Signaling in Monocrotaline-Induced Rats.
    Campos-Carraro C, Turck P, de Lima-Seolin BG, Tavares AMV, Dos Santos Lacerda D, Corssac GB, Teixeira RB, Hickmann A, Llesuy S, da Rosa Araujo AS, Belló-Klein A.
    J Cardiovasc Pharmacol; 2018 Nov 01; 72(5):214-221. PubMed ID: 30212415
    [Abstract] [Full Text] [Related]

  • 29. Chrysin Alleviates Monocrotaline-Induced Pulmonary Hypertension in Rats Through Regulation of Intracellular Calcium Homeostasis in Pulmonary Arterial Smooth Muscle Cells.
    Dong F, Zhang J, Chen X, Zhang S, Zhu L, Peng Y, Guo Z.
    J Cardiovasc Pharmacol; 2020 Jun 01; 75(6):596-602. PubMed ID: 32168153
    [Abstract] [Full Text] [Related]

  • 30. Changes in alpha(1)-adrenergic vascular reactivity in monocrotaline-treated rats.
    Dhein S, Giessler C, Heinroth-Hoffmann I, Leineweber K, Seyfarth T, Brodde OE.
    Naunyn Schmiedebergs Arch Pharmacol; 2002 Feb 01; 365(2):87-95. PubMed ID: 11819025
    [Abstract] [Full Text] [Related]

  • 31. Urotensin II receptor antagonist attenuates monocrotaline-induced cardiac hypertrophy in rats.
    Gao S, Oh YB, Shah A, Park WH, Chung MJ, Lee YH, Kim SH.
    Am J Physiol Heart Circ Physiol; 2010 Dec 01; 299(6):H1782-9. PubMed ID: 20870804
    [Abstract] [Full Text] [Related]

  • 32. The remodeling of connexin in the hypertrophied right ventricular in pulmonary arterial hypertension and the effect of a dual ET receptor antagonist (bosentan).
    Tan XY, He JG.
    Pathol Res Pract; 2009 Dec 01; 205(7):473-82. PubMed ID: 19232841
    [Abstract] [Full Text] [Related]

  • 33. Preventive effect of sildenafil on right ventricular function in rats with monocrotaline-induced pulmonary arterial hypertension.
    Yoshiyuki R, Tanaka R, Fukushima R, Machida N.
    Exp Anim; 2016 Jul 29; 65(3):215-22. PubMed ID: 26876436
    [Abstract] [Full Text] [Related]

  • 34. Total ginsenosides inhibit the right ventricular hypertrophy induced by monocrotaline in rats.
    Qin N, Gong QH, Wei LW, Wu Q, Huang XN.
    Biol Pharm Bull; 2008 Aug 29; 31(8):1530-5. PubMed ID: 18670084
    [Abstract] [Full Text] [Related]

  • 35. Ca2+ handling remodeling and STIM1L/Orai1/TRPC1/TRPC4 upregulation in monocrotaline-induced right ventricular hypertrophy.
    Sabourin J, Boet A, Rucker-Martin C, Lambert M, Gomez AM, Benitah JP, Perros F, Humbert M, Antigny F.
    J Mol Cell Cardiol; 2018 May 29; 118():208-224. PubMed ID: 29634917
    [Abstract] [Full Text] [Related]

  • 36. Resveratrol inhibits right ventricular hypertrophy induced by monocrotaline in rats.
    Yang DL, Zhang HG, Xu YL, Gao YH, Yang XJ, Hao XQ, Li XH.
    Clin Exp Pharmacol Physiol; 2010 Feb 29; 37(2):150-5. PubMed ID: 19566840
    [Abstract] [Full Text] [Related]

  • 37. 2-Methoxyestradiol mediates the protective effects of estradiol in monocrotaline-induced pulmonary hypertension.
    Tofovic SP, Zhang X, Jackson EK, Dacic S, Petrusevska G.
    Vascul Pharmacol; 2006 Dec 29; 45(6):358-67. PubMed ID: 16872912
    [Abstract] [Full Text] [Related]

  • 38. Enhanced gene expression of renin-angiotensin system, TGF-beta1, endothelin-1 and nitric oxide synthase in right-ventricular hypertrophy.
    Park HK, Park SJ, Kim CS, Paek YW, Lee JU, Lee WJ.
    Pharmacol Res; 2001 Mar 29; 43(3):265-73. PubMed ID: 11401419
    [Abstract] [Full Text] [Related]

  • 39. Role of endothelin ETB receptor in the pathogenesis of monocrotaline-induced pulmonary hypertension in rats.
    Nishida M, Okada Y, Akiyoshi K, Eshiro K, Takoaka M, Gariepy CE, Yanagisawa M, Matsumura Y.
    Eur J Pharmacol; 2004 Aug 02; 496(1-3):159-65. PubMed ID: 15359489
    [Abstract] [Full Text] [Related]

  • 40. Role of nitric oxide and endothelin-1 in monocrotaline-induced pulmonary hypertension in rats.
    Mathew R, Zeballos GA, Tun H, Gewitz MH.
    Cardiovasc Res; 1995 Nov 02; 30(5):739-46. PubMed ID: 8595621
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 12.